Pharmaust

PharmAust specialises in the relaunch of existing marketed products for oncology applications making the whole development

PharmAust acquired Pitney Pharmaceuticals Ltd and raised funds to develop its product pipeline, which now includes both human and veterinary proprietary medicines to treat cancer. As a result, PharmAust now also has two key strategic alliances with major pharmaceutical companies and products already in phase II trials. These products target substantial multi-billion dollar markets.